The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-11-16

AUTHORS

Jianyong Zhuo, Di Lu, Zuyuan Lin, Xinyu Yang, Modan Yang, Jianguo Wang, Yaoye Tao, Xue Wen, Huihui Li, Zhengxing Lian, Beini Cen, Siyi Dong, Xuyong Wei, Haiyang Xie, Shusen Zheng, Youqing Shen, Xiao Xu

ABSTRACT

Cytokeratin 19-positive (CK19+) hepatocellular carcinoma (HCC) is an aggressive subtype characterized by early recurrence and chemotherapy tolerance. However, there is no specific therapeutic option for CK19+ HCC. The correlation between tumor recurrence and expression status of CK19 were studied in 206 patients undergoing liver transplantation for HCC. CK19−/+ HCC cells were isolated to screen effective antitumor drugs. The therapeutic effects of regorafenib were evaluated in patient-derived xenograft (PDX) models from 10 HCC patients. The mechanism of regorafenib on CK19+ HCC was investigated. CK19 positiveness indicated aggressiveness of tumor and higher recurrence risk of HCC after liver transplantation. The isolated CK19+ HCC cells had more aggressive behaviors than CK19− cells. Regorafenib preferentially increased the growth inhibition and apoptosis of CK19+ cells in vitro, whereas sorafenib, apatinib, and 5-fluorouracil did not. In PDX models from CK19−/+ HCC patients, the tumor control rate of regorafenib achieved 80% for CK19+ HCCs, whereas 0% for CK19− HCCs. RNA-sequencing revealed that CK19+ cells had elevated expression of mitochondrial ribosomal proteins, which are essential for mitochondrial function. Further experiments confirmed that regorafenib attenuated the mitochondrial respiratory capacity in CK19+ cells. However, the mitochondrial respiration in CK19− cells were faint and hardly repressed by regorafenib. The mitochondrial respiration was regulated by the phosphorylation of signal transducer and activator of transcription 3 (STAT3), which was inhibited by regorafenib in CK19+ cells. Hence, CK19 could be a potential marker of the therapeutic benefit of regorafenib, which facilitates the individualized therapy for HCC. STAT3/mitochondria axis determines the distinct response of CK19+ cells to regorafenib treatment. More... »

PAGES

1084

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41419-021-04320-4

DOI

http://dx.doi.org/10.1038/s41419-021-04320-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1142597368

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34785656


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Hepatocellular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Keratin-19", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenylurea Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyridines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transfection", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institute of Organ Transplantation, Zhejiang University School of Medicine, Hangzhou, China", 
          "id": "http://www.grid.ac/institutes/grid.13402.34", 
          "name": [
            "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China", 
            "Institute of Organ Transplantation, Zhejiang University School of Medicine, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhuo", 
        "givenName": "Jianyong", 
        "id": "sg:person.014227113347.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014227113347.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China", 
          "id": "http://www.grid.ac/institutes/grid.13402.34", 
          "name": [
            "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lu", 
        "givenName": "Di", 
        "id": "sg:person.0737072544.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737072544.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China", 
          "id": "http://www.grid.ac/institutes/grid.13402.34", 
          "name": [
            "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lin", 
        "givenName": "Zuyuan", 
        "id": "sg:person.014743364463.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014743364463.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China", 
          "id": "http://www.grid.ac/institutes/grid.13402.34", 
          "name": [
            "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "Xinyu", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China", 
          "id": "http://www.grid.ac/institutes/grid.13402.34", 
          "name": [
            "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "Modan", 
        "id": "sg:person.014660302322.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014660302322.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China", 
          "id": "http://www.grid.ac/institutes/grid.13402.34", 
          "name": [
            "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Jianguo", 
        "id": "sg:person.012462600540.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012462600540.64"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China", 
          "id": "http://www.grid.ac/institutes/grid.13402.34", 
          "name": [
            "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tao", 
        "givenName": "Yaoye", 
        "id": "sg:person.010770510021.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010770510021.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China", 
          "id": "http://www.grid.ac/institutes/grid.13402.34", 
          "name": [
            "Department of Pathology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wen", 
        "givenName": "Xue", 
        "id": "sg:person.015654072333.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015654072333.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China", 
          "id": "http://www.grid.ac/institutes/grid.13402.34", 
          "name": [
            "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Huihui", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China", 
          "id": "http://www.grid.ac/institutes/grid.13402.34", 
          "name": [
            "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lian", 
        "givenName": "Zhengxing", 
        "id": "sg:person.012621156263.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012621156263.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China", 
          "id": "http://www.grid.ac/institutes/grid.13402.34", 
          "name": [
            "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cen", 
        "givenName": "Beini", 
        "id": "sg:person.012023575663.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012023575663.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Center for Healthcare Quality Management in Liver Transplant, Hangzhou, China", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "National Center for Healthcare Quality Management in Liver Transplant, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dong", 
        "givenName": "Siyi", 
        "id": "sg:person.016621314010.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016621314010.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China", 
          "id": "http://www.grid.ac/institutes/grid.13402.34", 
          "name": [
            "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wei", 
        "givenName": "Xuyong", 
        "id": "sg:person.0636727021.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636727021.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Health Commission Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, China", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Institute of Organ Transplantation, Zhejiang University School of Medicine, Hangzhou, China", 
            "Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China", 
            "National Health Commission Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xie", 
        "givenName": "Haiyang", 
        "id": "sg:person.0657720126.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657720126.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital, Hangzhou, China", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Institute of Organ Transplantation, Zhejiang University School of Medicine, Hangzhou, China", 
            "National Center for Healthcare Quality Management in Liver Transplant, Hangzhou, China", 
            "Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China", 
            "National Health Commission Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, China", 
            "Department of Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zheng", 
        "givenName": "Shusen", 
        "id": "sg:person.0640501242.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640501242.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Bionanoengineering and Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, China", 
          "id": "http://www.grid.ac/institutes/grid.13402.34", 
          "name": [
            "Center for Bionanoengineering and Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shen", 
        "givenName": "Youqing", 
        "id": "sg:person.01120713444.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01120713444.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Center for Healthcare Quality Management in Liver Transplant, Hangzhou, China", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, China", 
            "Institute of Organ Transplantation, Zhejiang University School of Medicine, Hangzhou, China", 
            "National Center for Healthcare Quality Management in Liver Transplant, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xu", 
        "givenName": "Xiao", 
        "id": "sg:person.0710354226.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0710354226.21"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/s41568-018-0090-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1110828412", 
          "https://doi.org/10.1038/s41568-018-0090-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature13611", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013589867", 
          "https://doi.org/10.1038/nature13611"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2017.260", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091083456", 
          "https://doi.org/10.1038/onc.2017.260"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1209558", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051714789", 
          "https://doi.org/10.1038/sj.onc.1209558"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12885-016-2949-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019609414", 
          "https://doi.org/10.1186/s12885-016-2949-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrclinonc.2012.61", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013064241", 
          "https://doi.org/10.1038/nrclinonc.2012.61"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/labinvest.2010.161", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027876727", 
          "https://doi.org/10.1038/labinvest.2010.161"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-11-16", 
    "datePublishedReg": "2021-11-16", 
    "description": "Cytokeratin 19-positive (CK19+) hepatocellular carcinoma (HCC) is an aggressive subtype characterized by early recurrence and chemotherapy tolerance. However, there is no specific therapeutic option for CK19+ HCC. The correlation between tumor recurrence and expression status of CK19 were studied in 206 patients undergoing liver transplantation for HCC. CK19\u2212/+ HCC cells were isolated to screen effective antitumor drugs. The therapeutic effects of regorafenib were evaluated in patient-derived xenograft (PDX) models from 10 HCC patients. The mechanism of regorafenib on CK19+ HCC was investigated. CK19 positiveness indicated aggressiveness of tumor and higher recurrence risk of HCC after liver transplantation. The isolated CK19+ HCC cells had more aggressive behaviors than CK19\u2212 cells. Regorafenib preferentially increased the growth inhibition and apoptosis of CK19+ cells in vitro, whereas sorafenib, apatinib, and 5-fluorouracil did not. In PDX models from CK19\u2212/+ HCC patients, the tumor control rate of regorafenib achieved 80% for CK19+ HCCs, whereas 0% for CK19\u2212 HCCs. RNA-sequencing revealed that CK19+ cells had elevated expression of mitochondrial ribosomal proteins, which are essential for mitochondrial function. Further experiments confirmed that regorafenib attenuated the mitochondrial respiratory capacity in CK19+ cells. However, the mitochondrial respiration in CK19\u2212 cells were faint and hardly repressed by regorafenib. The mitochondrial respiration was regulated by the phosphorylation of signal transducer and activator of transcription 3 (STAT3), which was inhibited by regorafenib in CK19+ cells. Hence, CK19 could be a potential marker of the therapeutic benefit of regorafenib, which facilitates the individualized therapy for HCC. STAT3/mitochondria axis determines the distinct response of CK19+ cells to regorafenib treatment.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s41419-021-04320-4", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1042939", 
        "issn": [
          "2041-4889"
        ], 
        "name": "Cell Death & Disease", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "keywords": [
      "hepatocellular carcinoma", 
      "liver transplantation", 
      "HCC patients", 
      "HCC cells", 
      "patient-derived xenograft models", 
      "mechanism of regorafenib", 
      "tumor control rate", 
      "specific therapeutic options", 
      "high recurrence risk", 
      "aggressiveness of tumors", 
      "chemotherapy tolerance", 
      "effective antitumor drugs", 
      "early recurrence", 
      "therapeutic options", 
      "mitochondrial respiratory capacity", 
      "tumor recurrence", 
      "control rate", 
      "mitochondrial respiration", 
      "aggressive subtype", 
      "PDX models", 
      "therapeutic effect", 
      "individualized therapy", 
      "regorafenib", 
      "xenograft model", 
      "therapeutic benefit", 
      "recurrence risk", 
      "CK19", 
      "expression status", 
      "patients", 
      "potential marker", 
      "elevated expression", 
      "mitochondria axis", 
      "distinct responsiveness", 
      "transplantation", 
      "carcinoma", 
      "recurrence", 
      "mitochondrial function", 
      "transcription 3", 
      "aggressive behavior", 
      "respiratory capacity", 
      "growth inhibition", 
      "antitumor drugs", 
      "RNA sequencing", 
      "signal transducer", 
      "cells", 
      "apatinib", 
      "sorafenib", 
      "therapy", 
      "tumors", 
      "cytokeratin", 
      "subtypes", 
      "drugs", 
      "distinct responses", 
      "Further experiments", 
      "treatment", 
      "risk", 
      "apoptosis", 
      "vitro", 
      "responsiveness", 
      "inhibition", 
      "markers", 
      "aggressiveness", 
      "status", 
      "options", 
      "expression", 
      "activator", 
      "phosphorylation", 
      "respiration", 
      "response", 
      "protein", 
      "benefits", 
      "rate", 
      "correlation", 
      "effect", 
      "tolerance", 
      "mechanism", 
      "axis", 
      "function", 
      "mitochondrial ribosomal proteins", 
      "model", 
      "transducer", 
      "capacity", 
      "ribosomal proteins", 
      "positiveness", 
      "behavior", 
      "experiments"
    ], 
    "name": "The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib", 
    "pagination": "1084", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1142597368"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41419-021-04320-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34785656"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41419-021-04320-4", 
      "https://app.dimensions.ai/details/publication/pub.1142597368"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:49", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_904.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s41419-021-04320-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41419-021-04320-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41419-021-04320-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41419-021-04320-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41419-021-04320-4'


 

This table displays all metadata directly associated to this object as RDF triples.

344 TRIPLES      21 PREDICATES      129 URIs      114 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41419-021-04320-4 schema:about N116db29b0b654573a0652c3bb44f0a3a
2 N2cebd62d0cfb46c1b380b19fe40f0d37
3 N511ca49d994f4e04853395f6896dca41
4 N69cedb36551a48a0b46df84802a8d7c2
5 N92068979a3d24d7c8aa7094194e45f4f
6 Nb7e23d872b6640e387fc0057cee72db7
7 Nb82b8bdca9bc4181ace436d5ac48714f
8 Ncb66cac3085e49ffa8db934c0966f4ef
9 Nf0e49ecc1a0e4709bedf2e543228bd17
10 Nf8b84e1adfa34c368ae02fcf85ebc66a
11 Nf8e279acf2a44ef0bbcafbef6f5d4124
12 anzsrc-for:11
13 anzsrc-for:1112
14 schema:author N888d2779715140af98006637fe6472db
15 schema:citation sg:pub.10.1038/labinvest.2010.161
16 sg:pub.10.1038/nature13611
17 sg:pub.10.1038/nrclinonc.2012.61
18 sg:pub.10.1038/onc.2017.260
19 sg:pub.10.1038/s41568-018-0090-8
20 sg:pub.10.1038/sj.onc.1209558
21 sg:pub.10.1186/s12885-016-2949-y
22 schema:datePublished 2021-11-16
23 schema:datePublishedReg 2021-11-16
24 schema:description Cytokeratin 19-positive (CK19+) hepatocellular carcinoma (HCC) is an aggressive subtype characterized by early recurrence and chemotherapy tolerance. However, there is no specific therapeutic option for CK19+ HCC. The correlation between tumor recurrence and expression status of CK19 were studied in 206 patients undergoing liver transplantation for HCC. CK19−/+ HCC cells were isolated to screen effective antitumor drugs. The therapeutic effects of regorafenib were evaluated in patient-derived xenograft (PDX) models from 10 HCC patients. The mechanism of regorafenib on CK19+ HCC was investigated. CK19 positiveness indicated aggressiveness of tumor and higher recurrence risk of HCC after liver transplantation. The isolated CK19+ HCC cells had more aggressive behaviors than CK19− cells. Regorafenib preferentially increased the growth inhibition and apoptosis of CK19+ cells in vitro, whereas sorafenib, apatinib, and 5-fluorouracil did not. In PDX models from CK19−/+ HCC patients, the tumor control rate of regorafenib achieved 80% for CK19+ HCCs, whereas 0% for CK19− HCCs. RNA-sequencing revealed that CK19+ cells had elevated expression of mitochondrial ribosomal proteins, which are essential for mitochondrial function. Further experiments confirmed that regorafenib attenuated the mitochondrial respiratory capacity in CK19+ cells. However, the mitochondrial respiration in CK19− cells were faint and hardly repressed by regorafenib. The mitochondrial respiration was regulated by the phosphorylation of signal transducer and activator of transcription 3 (STAT3), which was inhibited by regorafenib in CK19+ cells. Hence, CK19 could be a potential marker of the therapeutic benefit of regorafenib, which facilitates the individualized therapy for HCC. STAT3/mitochondria axis determines the distinct response of CK19+ cells to regorafenib treatment.
25 schema:genre article
26 schema:isAccessibleForFree true
27 schema:isPartOf N27ee3217d4fb4590b8c10abf81fd446d
28 Nb850bebcc4ab4765b2c8302e0655a431
29 sg:journal.1042939
30 schema:keywords CK19
31 Further experiments
32 HCC cells
33 HCC patients
34 PDX models
35 RNA sequencing
36 activator
37 aggressive behavior
38 aggressive subtype
39 aggressiveness
40 aggressiveness of tumors
41 antitumor drugs
42 apatinib
43 apoptosis
44 axis
45 behavior
46 benefits
47 capacity
48 carcinoma
49 cells
50 chemotherapy tolerance
51 control rate
52 correlation
53 cytokeratin
54 distinct responses
55 distinct responsiveness
56 drugs
57 early recurrence
58 effect
59 effective antitumor drugs
60 elevated expression
61 experiments
62 expression
63 expression status
64 function
65 growth inhibition
66 hepatocellular carcinoma
67 high recurrence risk
68 individualized therapy
69 inhibition
70 liver transplantation
71 markers
72 mechanism
73 mechanism of regorafenib
74 mitochondria axis
75 mitochondrial function
76 mitochondrial respiration
77 mitochondrial respiratory capacity
78 mitochondrial ribosomal proteins
79 model
80 options
81 patient-derived xenograft models
82 patients
83 phosphorylation
84 positiveness
85 potential marker
86 protein
87 rate
88 recurrence
89 recurrence risk
90 regorafenib
91 respiration
92 respiratory capacity
93 response
94 responsiveness
95 ribosomal proteins
96 risk
97 signal transducer
98 sorafenib
99 specific therapeutic options
100 status
101 subtypes
102 therapeutic benefit
103 therapeutic effect
104 therapeutic options
105 therapy
106 tolerance
107 transcription 3
108 transducer
109 transplantation
110 treatment
111 tumor control rate
112 tumor recurrence
113 tumors
114 vitro
115 xenograft model
116 schema:name The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib
117 schema:pagination 1084
118 schema:productId N85596d1ef83e4cf19e286e96f171605f
119 Na9d39443f7e04a3687397b75ccf48ece
120 Nd7403719b0744ec694eb2711fa7dfff9
121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1142597368
122 https://doi.org/10.1038/s41419-021-04320-4
123 schema:sdDatePublished 2022-10-01T06:49
124 schema:sdLicense https://scigraph.springernature.com/explorer/license/
125 schema:sdPublisher N91d64482a9c144af85e28c2cca6cb757
126 schema:url https://doi.org/10.1038/s41419-021-04320-4
127 sgo:license sg:explorer/license/
128 sgo:sdDataset articles
129 rdf:type schema:ScholarlyArticle
130 N06f393107fdf4f0ca8620903ecf5098a rdf:first sg:person.014743364463.13
131 rdf:rest Nf0614125cf94429689149a9dc247ddef
132 N116db29b0b654573a0652c3bb44f0a3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Keratin-19
134 rdf:type schema:DefinedTerm
135 N27ee3217d4fb4590b8c10abf81fd446d schema:volumeNumber 12
136 rdf:type schema:PublicationVolume
137 N2cebd62d0cfb46c1b380b19fe40f0d37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Humans
139 rdf:type schema:DefinedTerm
140 N2d7e7c97a8c447a9ba2472e033448ee6 rdf:first sg:person.012023575663.23
141 rdf:rest N32cf1f48f49c4e8aab9a832fae49ed69
142 N32cf1f48f49c4e8aab9a832fae49ed69 rdf:first sg:person.016621314010.23
143 rdf:rest N665626e26b63431aa32e47a52be5bf0f
144 N511ca49d994f4e04853395f6896dca41 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Liver Neoplasms
146 rdf:type schema:DefinedTerm
147 N53cc9a5cbccd487e9299c3bdb2f7413b schema:affiliation grid-institutes:grid.13402.34
148 schema:familyName Li
149 schema:givenName Huihui
150 rdf:type schema:Person
151 N665626e26b63431aa32e47a52be5bf0f rdf:first sg:person.0636727021.03
152 rdf:rest N67fcef5ca8504cbc86899b279d25e138
153 N67fcef5ca8504cbc86899b279d25e138 rdf:first sg:person.0657720126.04
154 rdf:rest Nf62f3e864c664cc4866330a38c45d378
155 N69cedb36551a48a0b46df84802a8d7c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Male
157 rdf:type schema:DefinedTerm
158 N6ab29e02b33e47be97c62300f1771a8d rdf:first sg:person.015654072333.95
159 rdf:rest Na2344399772f4d1790cfb42f58b44da7
160 N85596d1ef83e4cf19e286e96f171605f schema:name dimensions_id
161 schema:value pub.1142597368
162 rdf:type schema:PropertyValue
163 N888d2779715140af98006637fe6472db rdf:first sg:person.014227113347.05
164 rdf:rest Nca82beda58294698a1c20ab056b80a85
165 N89c168faf75f46a7acdaee8b2d4d629f rdf:first sg:person.01120713444.83
166 rdf:rest Ncc06dfeeb43b429d816b5cddb52e4c8a
167 N91d64482a9c144af85e28c2cca6cb757 schema:name Springer Nature - SN SciGraph project
168 rdf:type schema:Organization
169 N92068979a3d24d7c8aa7094194e45f4f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Phenylurea Compounds
171 rdf:type schema:DefinedTerm
172 Na2344399772f4d1790cfb42f58b44da7 rdf:first N53cc9a5cbccd487e9299c3bdb2f7413b
173 rdf:rest Nc00bb195e3474858b2bd43771c800157
174 Na30b2ac3a302415dbd761f33a99d0959 rdf:first sg:person.010770510021.00
175 rdf:rest N6ab29e02b33e47be97c62300f1771a8d
176 Na327de5647b1450283cca8ee7a260e29 rdf:first sg:person.014660302322.01
177 rdf:rest Na4eccb2bde9f48419677a9f706f2eb91
178 Na4eccb2bde9f48419677a9f706f2eb91 rdf:first sg:person.012462600540.64
179 rdf:rest Na30b2ac3a302415dbd761f33a99d0959
180 Na9d39443f7e04a3687397b75ccf48ece schema:name doi
181 schema:value 10.1038/s41419-021-04320-4
182 rdf:type schema:PropertyValue
183 Nb1a8bf1af4ab47acb3ad9eec2e0801e5 schema:affiliation grid-institutes:grid.13402.34
184 schema:familyName Yang
185 schema:givenName Xinyu
186 rdf:type schema:Person
187 Nb7e23d872b6640e387fc0057cee72db7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Animals
189 rdf:type schema:DefinedTerm
190 Nb82b8bdca9bc4181ace436d5ac48714f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Mice
192 rdf:type schema:DefinedTerm
193 Nb850bebcc4ab4765b2c8302e0655a431 schema:issueNumber 12
194 rdf:type schema:PublicationIssue
195 Nc00bb195e3474858b2bd43771c800157 rdf:first sg:person.012621156263.27
196 rdf:rest N2d7e7c97a8c447a9ba2472e033448ee6
197 Nca82beda58294698a1c20ab056b80a85 rdf:first sg:person.0737072544.80
198 rdf:rest N06f393107fdf4f0ca8620903ecf5098a
199 Ncb66cac3085e49ffa8db934c0966f4ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Pyridines
201 rdf:type schema:DefinedTerm
202 Ncc06dfeeb43b429d816b5cddb52e4c8a rdf:first sg:person.0710354226.21
203 rdf:rest rdf:nil
204 Nd7403719b0744ec694eb2711fa7dfff9 schema:name pubmed_id
205 schema:value 34785656
206 rdf:type schema:PropertyValue
207 Nf0614125cf94429689149a9dc247ddef rdf:first Nb1a8bf1af4ab47acb3ad9eec2e0801e5
208 rdf:rest Na327de5647b1450283cca8ee7a260e29
209 Nf0e49ecc1a0e4709bedf2e543228bd17 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
210 schema:name Transfection
211 rdf:type schema:DefinedTerm
212 Nf62f3e864c664cc4866330a38c45d378 rdf:first sg:person.0640501242.51
213 rdf:rest N89c168faf75f46a7acdaee8b2d4d629f
214 Nf8b84e1adfa34c368ae02fcf85ebc66a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
215 schema:name Survival Analysis
216 rdf:type schema:DefinedTerm
217 Nf8e279acf2a44ef0bbcafbef6f5d4124 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
218 schema:name Carcinoma, Hepatocellular
219 rdf:type schema:DefinedTerm
220 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
221 schema:name Medical and Health Sciences
222 rdf:type schema:DefinedTerm
223 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
224 schema:name Oncology and Carcinogenesis
225 rdf:type schema:DefinedTerm
226 sg:journal.1042939 schema:issn 2041-4889
227 schema:name Cell Death & Disease
228 schema:publisher Springer Nature
229 rdf:type schema:Periodical
230 sg:person.010770510021.00 schema:affiliation grid-institutes:grid.13402.34
231 schema:familyName Tao
232 schema:givenName Yaoye
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010770510021.00
234 rdf:type schema:Person
235 sg:person.01120713444.83 schema:affiliation grid-institutes:grid.13402.34
236 schema:familyName Shen
237 schema:givenName Youqing
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01120713444.83
239 rdf:type schema:Person
240 sg:person.012023575663.23 schema:affiliation grid-institutes:grid.13402.34
241 schema:familyName Cen
242 schema:givenName Beini
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012023575663.23
244 rdf:type schema:Person
245 sg:person.012462600540.64 schema:affiliation grid-institutes:grid.13402.34
246 schema:familyName Wang
247 schema:givenName Jianguo
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012462600540.64
249 rdf:type schema:Person
250 sg:person.012621156263.27 schema:affiliation grid-institutes:grid.13402.34
251 schema:familyName Lian
252 schema:givenName Zhengxing
253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012621156263.27
254 rdf:type schema:Person
255 sg:person.014227113347.05 schema:affiliation grid-institutes:grid.13402.34
256 schema:familyName Zhuo
257 schema:givenName Jianyong
258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014227113347.05
259 rdf:type schema:Person
260 sg:person.014660302322.01 schema:affiliation grid-institutes:grid.13402.34
261 schema:familyName Yang
262 schema:givenName Modan
263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014660302322.01
264 rdf:type schema:Person
265 sg:person.014743364463.13 schema:affiliation grid-institutes:grid.13402.34
266 schema:familyName Lin
267 schema:givenName Zuyuan
268 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014743364463.13
269 rdf:type schema:Person
270 sg:person.015654072333.95 schema:affiliation grid-institutes:grid.13402.34
271 schema:familyName Wen
272 schema:givenName Xue
273 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015654072333.95
274 rdf:type schema:Person
275 sg:person.016621314010.23 schema:affiliation grid-institutes:None
276 schema:familyName Dong
277 schema:givenName Siyi
278 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016621314010.23
279 rdf:type schema:Person
280 sg:person.0636727021.03 schema:affiliation grid-institutes:grid.13402.34
281 schema:familyName Wei
282 schema:givenName Xuyong
283 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636727021.03
284 rdf:type schema:Person
285 sg:person.0640501242.51 schema:affiliation grid-institutes:None
286 schema:familyName Zheng
287 schema:givenName Shusen
288 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0640501242.51
289 rdf:type schema:Person
290 sg:person.0657720126.04 schema:affiliation grid-institutes:None
291 schema:familyName Xie
292 schema:givenName Haiyang
293 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657720126.04
294 rdf:type schema:Person
295 sg:person.0710354226.21 schema:affiliation grid-institutes:None
296 schema:familyName Xu
297 schema:givenName Xiao
298 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0710354226.21
299 rdf:type schema:Person
300 sg:person.0737072544.80 schema:affiliation grid-institutes:grid.13402.34
301 schema:familyName Lu
302 schema:givenName Di
303 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737072544.80
304 rdf:type schema:Person
305 sg:pub.10.1038/labinvest.2010.161 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027876727
306 https://doi.org/10.1038/labinvest.2010.161
307 rdf:type schema:CreativeWork
308 sg:pub.10.1038/nature13611 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013589867
309 https://doi.org/10.1038/nature13611
310 rdf:type schema:CreativeWork
311 sg:pub.10.1038/nrclinonc.2012.61 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013064241
312 https://doi.org/10.1038/nrclinonc.2012.61
313 rdf:type schema:CreativeWork
314 sg:pub.10.1038/onc.2017.260 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091083456
315 https://doi.org/10.1038/onc.2017.260
316 rdf:type schema:CreativeWork
317 sg:pub.10.1038/s41568-018-0090-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1110828412
318 https://doi.org/10.1038/s41568-018-0090-8
319 rdf:type schema:CreativeWork
320 sg:pub.10.1038/sj.onc.1209558 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051714789
321 https://doi.org/10.1038/sj.onc.1209558
322 rdf:type schema:CreativeWork
323 sg:pub.10.1186/s12885-016-2949-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1019609414
324 https://doi.org/10.1186/s12885-016-2949-y
325 rdf:type schema:CreativeWork
326 grid-institutes:None schema:alternateName Department of Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital, Hangzhou, China
327 National Center for Healthcare Quality Management in Liver Transplant, Hangzhou, China
328 National Health Commission Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, China
329 schema:name Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
330 Department of Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital, Hangzhou, China
331 Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
332 Institute of Organ Transplantation, Zhejiang University School of Medicine, Hangzhou, China
333 National Center for Healthcare Quality Management in Liver Transplant, Hangzhou, China
334 National Health Commission Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, China
335 rdf:type schema:Organization
336 grid-institutes:grid.13402.34 schema:alternateName Center for Bionanoengineering and Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, China
337 Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
338 Department of Pathology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
339 Institute of Organ Transplantation, Zhejiang University School of Medicine, Hangzhou, China
340 schema:name Center for Bionanoengineering and Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, China
341 Department of Hepatobiliary and Pancreatic Surgery, Center for Integrated Oncology and Precision Medicine, the Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
342 Department of Pathology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
343 Institute of Organ Transplantation, Zhejiang University School of Medicine, Hangzhou, China
344 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...